Jagsonpal Pharmaceuticals standalone net profit rises 707.83% in the December 2024 quarter
Sales rise 56.74% to Rs 74.03 crore
Net profit of Jagsonpal Pharmaceuticals rose 707.83% to Rs 31.99 crore in the quarter ended December 2024 as against Rs 3.96 crore during the previous quarter ended December 2023. Sales rose 56.74% to Rs 74.03 crore in the quarter ended December 2024 as against Rs 47.23 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales74.0347.23 57 OPM %21.387.18 -PBDT17.905.68 215 PBT15.495.27 194 NP31.993.96 708Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content